Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | OPRM1 | P35372 | 13/20 | 0.53 |
| ▸ | DRD2 | P14416 | 4/20 | 0.46 |
| ▸ | DRD4 | P21917 | 4/20 | 0.46 |
| ▸ | DRD3 | P35462 | 3/20 | 0.46 |
| ▸ | CHRM1 | P11229 | 1/20 | 0.45 |
| ▸ | OPRK1 | P41145 | 2/20 | 0.45 |
| ▸ | OPRL1 | P41146 | 1/20 | 0.45 |
| ▸ | OPRD1 | P41143 | 1/20 | 0.45 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3125864 | 0.91 | OPRM1 (0.47) | OPRM1DRD2DRD4DRD3CHRM1 | |
| SCHEMBL3138400 | 0.89 | OPRM1 (0.54) | OPRM1DRD2DRD4DRD3CHRM1 | |
| SCHEMBL3091503 | 0.89 | OPRM1 (0.50) | OPRM1DRD2DRD4DRD3CHRM1 | |
| SCHEMBL3125828 | 0.88 | OPRM1 (0.52) | OPRM1DRD2DRD4DRD3CHRM1 | |
| SCHEMBL3141595 | 0.88 | OPRM1 (0.52) | OPRM1DRD2DRD4DRD3CHRM1 | |
| SCHEMBL3142452 | 0.87 | OPRM1 (0.51) | OPRM1DRD2DRD4DRD3CHRM1 | |
| SCHEMBL3133946 | 0.87 | OPRM1 (0.51) | OPRM1DRD2DRD4DRD3CHRM1 | |
| SCHEMBL3124946 | 0.85 | OPRM1 (0.52) | OPRM1DRD2DRD4DRD3CHRM1 | |
| SCHEMBL3138363 | 0.83 | ALDH1A1 (0.47) | SMN1; SMN2 | |
| SCHEMBL3134610 | 0.82 | OPRM1 (0.50) | OPRM1DRD2DRD3CHRM1OPRK1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2142528-B1 | 1-(1-BENZYLPIPERIDIN-4-YL)BENZIMIDAZ0LE -5-CARBOXYLIC ACID DERIVATIVES FOR THE TREATMENT OF DIABETES MELLITUS | HOFFMANN LA ROCHE (CH) | 2010-07-07 | — | — | EP | claimed |